{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T05:00:13Z","timestamp":1766379613162,"version":"3.48.0"},"reference-count":18,"publisher":"BMJ","issue":"6856","license":[{"start":{"date-parts":[[1992,9,26]],"date-time":"1992-09-26T00:00:00Z","timestamp":717465600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1992,9,26]]},"DOI":"10.1136\/bmj.305.6856.727","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T08:16:37Z","timestamp":1238400997000},"page":"727-728","source":"Crossref","is-referenced-by-count":15,"title":["Radioiodine for hyperthyroidism."],"prefix":"10.1136","volume":"305","author":[{"given":"J.","family":"Franklyn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1992,9,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1977.tb01340.x","article-title":"The spectrum of thyroid disease in a community","volume":"7","author":"Tunbridge, W.M.G.; Evered, D.C.; Hall, R.; Appleton, D.; Bruwis, M.; Clarke, F.","year":"1977","unstructured":"Tunbridge WMG, Evered DC, Hall R, Appleton D, Bruwis M, Clarke F, et al. The spectrum of thyroid disease in a community. Clin Endocrinol 1977;7:481-93.","journal-title":"Clin Endocrinol"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1210\/jcem-70-3-675","article-title":"Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration","volume":"70","author":"Allanic, H.; Fauchet, R.; Orgiazzi, J.; Madec, A.M.; Genetet, B.; Lorcy, Y.","year":"1990","unstructured":"Allanic H, Fauchet R, Orgiazzi J, Madec AM, Genetet B, Lorcy Y, et al. Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration. J Clin Endocrinol Metab 1990;70:675-9.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199104043241403","article-title":"Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to TSH receptors and on the risk of recurrence of hyperthyroidism","volume":"324","author":"Hashizume, K.; Ichikawa, K.; Sakurai, A.; Suzuki, S.; Takeda, T.; Kobayashi, M.","year":"1991","unstructured":"Hashizume K, Ichikawa K, Sakurai A, Suzuki S, Takeda T, Kobayashi M, et al. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to TSH receptors and on the risk of recurrence of hyperthyroidism. N EnglJ Med 1991;324:947-53. -","journal-title":"N EnglJ Med"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/thy.1991.1.129","article-title":"Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States","volume":"1","author":"Wartofsky, L.; Glinoer, D.; Solomon, D.","year":"1991","unstructured":"Wartofsky L, Glinoer D, Solomon D. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. Thyroid 1991;1:129-35.","journal-title":"Thyroid"},{"key":"ref_5","first-page":"71","article-title":"Long-term follow-up of treatment of thyrotoxicosis by three different methods","volume":"31","author":"Franklyn, J.A.; Daykin, J.; Drolc, Z.; Farmer, M.; Sheppard, M.C.","year":"1991","unstructured":"Franklyn JA, Daykin J, Drolc Z, Farmer M, Sheppard MC. Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clin Endocrinol 1991;31:71-6.","journal-title":"Clin Endocrinol"},{"key":"ref_6","first-page":"191","article-title":"Radioiodine therapy for Graves' disease: multivariate analysis of pretreatment parameters and early outcome","volume":"11","author":"Turner, J.; Sadler, W.; Brownlie, B.; Rogers, T.","year":"1985","unstructured":"Turner J, Sadler W, Brownlie B, Rogers T. Radioiodine therapy for Graves' disease: multivariate analysis of pretreatment parameters and early outcome. EurJ7 Nucl Med 1985;11: 191-3.","journal-title":"EurJ7 Nucl Med"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0002-9343(89)80485-1","article-title":"Treatment of Graves' disease and the course ofophthalmopathy","volume":"87","author":"Sridama, V.; DeGroot, L.","year":"1989","unstructured":"Sridama V, DeGroot L. Treatment of Graves' disease and the course ofophthalmopathy. AmJ Med 1989;87:70-3.","journal-title":"AmJ Med"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJM198911163212009","article-title":"Treatment of Graves' ophthalmopathy","volume":"321","author":"Utiger, R.D.","year":"1989","unstructured":"Utiger RD. Treatment of Graves' ophthalmopathy. N EnglJ Med 1989;321:1403-5.","journal-title":"N EnglJ Med"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00003072-198305000-00007","article-title":"Thyroid carcinoma after radioiodine therapy for hyperthyroidism: analysis based on age, latency and administered dose of 1-131","volume":"8","author":"Spencer, R.P.; Chapman, C.N.; Rao, H.","year":"1983","unstructured":"Spencer RP, Chapman CN, Rao H. Thyroid carcinoma after radioiodine therapy for hyperthyroidism: analysis based on age, latency and administered dose of 1-131. Clin Nuci Med 1983;8:216-9.","journal-title":"Clin Nuci Med"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1210\/jcem-38-6-976","article-title":"Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the co-operative thyrotoxicosis therapy follow-up study","volume":"38","author":"Dobyns, B.M.; Sheline, G.E.; Workman, J.B.; Thompkins, E.A.; McConatey, M.; Becker, D.U.","year":"1974","unstructured":"Dobyns BM, Sheline GE, Workman JB, Thompkins EA, McConatey M, Becker DU, et al. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the co-operative thyrotoxicosis therapy follow-up study. J Clin Endocrinol Metab 1974;38:976-8.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref_11","first-page":"1","article-title":"Leukaemia incidence after iodine-13 1 exposure","volume":"340","author":"Hall, P.; Boice, J.D.; Berg, G.; Bjelkengren, G.; Ericsson, U.-B.; Hallquist, A.","year":"1992","unstructured":"Hall P, Boice JD, Berg G, Bjelkengren G, Ericsson U-B, Hallquist A, et al. Leukaemia incidence after iodine-13 1 exposure. Lancet 1992;340:1-4.","journal-title":"Lancet"},{"key":"ref_12","first-page":"111","article-title":"Radioiodine therapy for thyrotoxicosis and risk of malignancy","volume-title":"prophylaxis following nuclear accidents","author":"Sheppard, M.C.","year":"1988","unstructured":"Sheppard MC. Radioiodine therapy for thyrotoxicosis and risk of malignancy. In: Rubery E, Smales E, eds. Iodine prophylaxis following nuclear accidents. London: Pergamon, 1988:111-8."},{"key":"ref_13","first-page":"961","article-title":"Radioactive iodine therapy and breast cancer","volume":"127","author":"Goldman, M.B.; Maloof, F.; Monson, R.R.; Aschengrau, A.; Cooer, D.S.; Ridgway, E.C.","year":"1988","unstructured":"Goldman MB, Maloof F, Monson RR, Aschengrau A, Cooer DS, Ridgway EC. Radioactive iodine therapy and breast cancer. Amj Epidemiol 1988;127:961-90.","journal-title":"Amj Epidemiol"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1056\/NEJM197501232920401","article-title":"Long-term follow-up results in children and adolescents treated with radioactive iodine for hyperthyroidism","volume":"292","author":"Safa, A.N.; Schmacher, O.P.; Rodriguez-Antunez, A.","year":"1975","unstructured":"Safa AN, Schmacher OP, Rodriguez-Antunez A. Long-term follow-up results in children and adolescents treated with radioactive iodine for hyperthyroidism. N EnglJ Med 1975;292:167-71.","journal-title":"N EnglJ Med"},{"key":"ref_15","first-page":"146","article-title":"Inadvertent 131-I therapy for hyperthyroidism in the first trimester of pregnancy","volume":"17","author":"Stoffer, S.S.; Hamburger, J.","year":"1975","unstructured":"Stoffer SS, Hamburger J. Inadvertent 131-I therapy for hyperthyroidism in the first trimester of pregnancy. J Nucl Med 1975;17:146-9.","journal-title":"J Nucl Med"},{"key":"ref_16","first-page":"826","article-title":"Gonadal radiation dose and its genetic significance in radioiodine therapy of hyperthyroidism","volume":"17","author":"Robertson, J.S.; Gorman, C.A.","year":"1976","unstructured":"Robertson JS, Gorman CA. Gonadal radiation dose and its genetic significance in radioiodine therapy of hyperthyroidism. J Nucl Med 1976;17:826-35.","journal-title":"J Nucl Med"},{"key":"ref_17","first-page":"460","article-title":"Subsequent fertility and birth histories ofchildren and adolescents treated with 131I for thyroid cancer","volume":"17","author":"Sarker, S.D.; Beierwaltes, W.H.; Gil, S.P.; Cowley, B.J.","year":"1976","unstructured":"Sarker SD, Beierwaltes WH, Gil SP, Cowley BJ. Subsequent fertility and birth histories ofchildren and adolescents treated with 131I for thyroid cancer;J Nucl Med 1976;17:460-4.","journal-title":"J Nucl Med"},{"key":"ref_18","article-title":"Non-stochastic effects of ionizing radiation","year":"1984","unstructured":"Non-stochastic effects of ionizing radiation. Annals of the International Commission on Radiological Protection 1984;14:No 3.","journal-title":"Annals of the International Commission on Radiological Protection; 14: No 3"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.305.6856.727","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.305.6856.727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T04:58:22Z","timestamp":1766379502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.305.6856.727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,9,26]]},"references-count":18,"journal-issue":{"issue":"6856","published-online":{"date-parts":[[1992,9,26]]},"published-print":{"date-parts":[[1992,9,26]]}},"alternative-id":["10.1136\/bmj.305.6856.727"],"URL":"https:\/\/doi.org\/10.1136\/bmj.305.6856.727","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"type":"print","value":"0959-8138"},{"type":"electronic","value":"1468-5833"}],"subject":[],"published":{"date-parts":[[1992,9,26]]}}}